Profile

Akiva Mintz, M.D., Ph.D.

Akiva Mintz, M.D., Ph.D.

Assistant Professor, Neurosurgery
Radiation Oncology-Radiation Biology
Contact Information
Office:
336-716-4081
Fax:
336-716-3065
Clinical Specialties
Noninvasive Imaging, Nuclear Medicine Oncologic Imaging, PET/CT, Molecular Imaging
Education & Training
  BACUNY Brooklyn College1997
  PhDPenn State University College of Medicine2002
  MDPenn State University College of Medicine2004
ResidencyNuclear MedicineHosp Of The Univ Penn2008
InternshipMedicineLehigh Valley Hosp Ctr2005
FellowshipNuclear MedicineUniversity of Pennsylvania2008
Board Certifications
American Board of Nuclear Medicine , Nuclear Medicine
Memberships
Society of Neuro-Oncology
Society of Nuclear Medicine
Radiological Society of North Amer
NPI Number
1245389956
Akiva Mintz, M.D., Ph.D.

Akiva Mintz, M.D., Ph.D.

Assistant Professor, Neurosurgery
Radiation Oncology-Radiation Biology
Contact Information
Office:
336-716-4081
Fax:
336-716-3065
Research Interests
biotechnology , cancer/oncogenesis , drugs/therapeutic agents pharm , nuclear medicine
Recent Publications

Kota G, Gupta P, Wilson J, Lesser G, Mintz A. Metastatic intracranial hemangiopericytoma: the role of octreotide and PET imaging in diagnosis, pre-treatment and follow-up evaluation [abstract]. J Nucl Med. 2011; 52(Suppl 1):abstr 1065.

Gupta P, Kota G, Alavi A, Mintz A. Unilateral diffusely increased muscle uptake of F-18 FDG in a patient with hemiparesis due to stroke. Clin Nucl Med. 2011; 36(12):1140-1141.

Nguyen V, Conyers JM, Zhu D, Gibo DM, Dorsey JF, Debinski W, Mintz A. IL-13R alpha2-targeted therapy escapees: biologic and therapeutic implications. Transl Oncol. 2011; 4(6):390-400.

Nguyen V, Conyers JM, Mintz A. Pretargeting the masses: a means of improving and mainstreaming targeted molecular delivery? [commentary]. Cancer Biol Ther. 2010; 10(8):775-779.

Kota GK, Gupta P, Conyers JM, Mintz A. Targeting angiogenesis in an age of personalized medicine [commentary]. Cancer Biol Ther. 2010; 10(9):874-877.

Hammond SN, Norden AD, Drappatz J, Phuphanich S, Reardon D, Wong ET, Plotkin SR, Lesser G, Mintz A, Raizer JJ, et al. Phase II study of monthly pasireotide LAR (Som230C) for recurrent or progressive meningioma [abstract]. Neuro Oncol. 2010; 12(71 Suppl 4):71.

Nguyen V, Murphy LT, Beauchamp AS, Hollingsworth CK, Debinski W, Mintz A. Combinatorial targeting of EphA2 and IL-13Ralpha2 GBM-restricted biomarkers [abstract]. Neuro Oncol. 2010; 12(Suppl 4):97.

Dorsey JF, Mintz A, Tian X, Dowling ML, Plastaras JP, Dicker DT, Kao GD, El-Deiry WS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther. 2009; 8(12):3285-3295.

Nguyen V, Mintz A. New frontiers in biomarker-targeted molecular imaging [commentary]. Cancer Biol Ther. 2009; 8(23):2235-2238.

Mintz A, Gibo DM, MadhanKumar AB, Cladel NM, Christensen ND, Debinski W. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2. Cancer Biother Radiopharm. 2008; 23(5):581-589.
All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Last Updated 3/31/2012
Quick Reference
Request an Appointment
New Patients
336-716-WAKE
888-716-WAKE
Existing patients may contact the clinic directly.
Find a Doctor

e.g., "allergy," "diabetes"

US News Best Hospital AwardANCC Magnet Association AwardBest Doctors 2011-2012 AwardConsumer Choice #1 Award 2011-2102US News Best Medical Schools 2011 Award

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.